Clinical Trial

A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes

Name: A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes — clinical trial record (NCT07755150)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study aims to assess the efficacy, safety, and PK characteristics of DA-302168S tablets in Chinese T2DM participants, and to provide dose-selection evidence for the Phase III confirmatory trial.

Trial Details

NCT Number	NCT07755150
Lead Sponsor	Chendu DIAO Pharmaceutical Group CO., LTD.
Conditions	Type 2 Diabetes Mellitus
Enrollment	272 participants
Start Date	2026-08-30
Primary Completion	2027-10-20 (estimated)
Study Completion	2027-10-20 (estimated)
Updated on ClinicalTrials.gov	2026-08-10